Antibody Sampler Kits
PhosphoPlus® MEK1/2 (Ser217/221) Antibody Kit
|
イイネ!(0)
|
|
| CSTコード |
包装 |
希望納入価格 (円) |
国内在庫  |
ご登録代理店情報  カスタマー情報にご登録いただいた代理店を表示しています。
ご登録代理店の変更は こちら。 |
| #9120S | 10 mini-blots | 100,000 | |
|
MEK1/2抗体製品一覧
9120 の推奨プロトコール
最適な結果を得るために:Cell Signaling Technology (CST) 社は、各製品の推奨プロトコールを使用することを強くお薦めいたします。
推奨プロトコールはCST社内試験の徹底的なバリデーションに基づいて作成されておりますので、正確かつ再現性の高い結果が得られます。
注:各製品に最適化されたプロトコールをリンクしています。
| | |
-
9122:
-
Immunoprecipitation
Western Blotting
-
9154:
-
Immunoprecipitation
Western Blotting
Western Blotting

Western blot analysis of extracts from untreated or TPA-treated HeLa and NIH/3T3 cells, using Phospho-MEK1/2 (Ser217/221) (41G9) Rabbit mAb #9154 (upper), or MEK1/2 Antibody #9122 (lower).
MEK1 and MEK2, also called MAPK or Erk kinases, are dual-specificity protein kinases that function in a mitogen activated protein kinase cascade controlling cell growth and differentiation (1-3). Activation of MEK1 and MEK2 occurs through phosphorylation of two serine residues at positions 217 and 221, located in the activation loop of subdomain VIII, by Raf-like molecules. MEK1/2 is activated by a wide variety of growth factors and cytokines and also by membrane depolarization and calcium influx (1-4). Constitutively active forms of MEK1/2 are sufficient for the transformation of NIH/3T3 cells or the differentiation of PC-12 cells (4). MEK activates p44 and p42 MAP kinase by phosphorylating both threonine and tyrosine residues at sites located within the activation loop of kinase subdomain VIII.
-
Crews, C.M. et al. (1992) Science 258, 478-480.
-
Alessi, D.R. et al. (1994) EMBO J. 13, 1610-1619.
-
Rosen, L.B. et al. (1994) Neuron 12, 1207-1221.
-
Cowley, S. et al. (1994) Cell 77, 841-852.
- Xiao, D. and Singh, S.V. (2002) Phenethyl isothiocyanate-induced apoptosis in p53-deficient PC-3 human prostate cancer cell line is mediated by extracellular signal-regulated kinases. Cancer Res. 62, 3615-3619. Applications: Western Blotting
- Watanabe, H. et al. (2001) Transcriptional cross-talk between Smad, ERK1/2, and p38 mitogen-activated protein kinase pathways regulates transforming growth factor-beta-induced aggrecan gene expression in chondrogenic ATDC5 cells. J. Biol. Chem. 276, 14466-14473. Applications: Western Blotting
- Jost, M. et al. (2001) Epidermal growth factor receptor-dependent control of keratinocyte survival and Bcl-xL expression through a MEK-dependent pathway. J. Biol. Chem. 276, 6320-6326. Applications: Western Blotting
- DeWindt, L. J. et al. (2000) Calcineurin promotes protein kinase C and c-Jun NH2-terminal kinase activation in the heart. Journal of Biological Chemistry 275, 13571-13579. Applications: Western Blotting
- Soga, S. et al. (1998) Radicicol leads to selective depletion of Raf kinase and disrupts K-Ras-activated aberrant signaling pathway. Journal of Biological Chemistry 273, 822-828. Applications: Western Blotting
- Galbiati, F. et al. (1998) Targeted downregulation of caveolin-1 is sufficient to drive cell transformation and hyperactivate the p42/44 MAP kinasecascade. European Molecular Biology Organization (EMBO) 17, 6633-6648. Applications: Western Blotting